Researchers identify 10 pesticides toxic to neurons involved in Parkinson & #039;s
Researchers at UCLA Health and Harvard have identified 10 pesticides that significantly damaged neurons implicated in the development of Parkinson’s disease, providing new clues about environmental toxins' role in the disease.
While environmental factors such as pesticide exposure have long been linked to Parkinson's, it has been harder to pinpoint which pesticides may raise risk for the neurodegenerative disorder. (Source: World Pharma News)
Source: World Pharma News - May 17, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Bayer receives U.S. FDA Fast Track Designation for asundexian atrial fibrillation program
Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its investigational drug asundexian (BAY2433334) as a potential treatment to prevent stroke and systemic embolism in people with atrial fibrillation (AF). This news follows asundexian's first U.S. FDA Fast Track Designation for the prevention of stroke in patients after a non-cardioembolic ischemic stroke, which was granted in 2022. (Source: World Pharma News)
Source: World Pharma News - May 16, 2023 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news
Newly discovered RNA molecules hold promise for detecting and treating esophageal cancer
Irregularities in the body's genetic coding to make proteins are linked to cancerous tumors. But most genetic material contains elements whose function isn’t clear.
Could abnormalities in non-coding material also impact a person’s health, or even be linked to cancers as well? (Source: World Pharma News)
Source: World Pharma News - May 15, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
New research sheds light on the causes of fatigue after COVID 19
Experts from Newcastle University found the nervous system of people with post-COVID fatigue was underactive in three key areas. Fatigue is one of the most common symptoms of long COVID.
The breakthrough could lead to better treatment and tests to identify the condition and the team are already progressing the work having just started a trial. (Source: World Pharma News)
Source: World Pharma News - May 12, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
FDA approves first drug to treat agitation symptoms associated with dementia due to Alzheimer & #039;s disease
Today, the U.S. Food and Drug Administration is announcing the supplemental approval of Rexulti (brexpiprazole) oral tablets for the treatment of agitation associated with dementia due to Alzheimer’s disease. This is the first FDA-approved treatment option for this indication. (Source: World Pharma News)
Source: World Pharma News - May 11, 2023 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news
Bayer opens first Co.Lab Life science incubator in Cambridge
Bayer AG announced the inauguration of its new life science incubator dubbed "Co.Lab Cambridge" located in Kendall Square in Cambridge, U.S.. Bayer's Co.Lab Cambridge is specifically designed to support cutting-edge cell and gene therapies (CGT) entrepreneurs with access to Bayer's enterprise wide expertise in addition to state-of-the art laboratory and office space. (Source: World Pharma News)
Source: World Pharma News - May 10, 2023 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news
Reduced cancer mortality with daily vitamin D intake
Vitamin D intake could reduce cancer mortality in the population by twelve percent - provided the vitamin is taken daily. This was the result of an evaluation of 14 studies of the highest quality conducted at the German Cancer Research Center with a total of almost 105,000 participants.
Vitamin D deficiency is widespread worldwide and is particularly common among cancer patients. (Source: World Pharma News)
Source: World Pharma News - May 9, 2023 Category: Pharmaceuticals Tags: Featured Events Source Type: news
Roche launches Institute of Human Biology to accelerate breakthroughs in R & D by unlocking the potential of human model systems
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the launch of the Institute of Human Biology (IHB) focussing on advancing research in the field of human model systems such as organoids. Leveraging human model systems, the institute aims to accelerate drug discovery and development by improving the understanding of how organs function and how diseases develop. (Source: World Pharma News)
Source: World Pharma News - May 8, 2023 Category: Pharmaceuticals Tags: Featured Roche Business and Industry Source Type: news
Discovery suggests route to safer pain medications
Strategies to treat pain without triggering dangerous side effects such as euphoria and addiction have proven elusive. For decades, scientists have attempted to develop drugs that selectively activate one type of opioid receptor to treat pain while not activating another type of opioid receptor linked to addiction. Unfortunately, those compounds can cause a different unwanted effect: hallucinations. (Source: World Pharma News)
Source: World Pharma News - May 5, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
FDA approves first respiratory syncytial virus (RSV) vaccine
The U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy is approved for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older. (Source: World Pharma News)
Source: World Pharma News - May 4, 2023 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news
& #039;Black sheep & #039; of helper T cells may hold key to precision allergy treatment
A new Nature Immunology study led by University of Pittsburgh and National Institutes of Health researchers sheds light on how a rare type of helper T cell, called Th9, can drive allergic disease, suggesting new precision medicine approaches to treating allergies in patients with high levels of Th9. (Source: World Pharma News)
Source: World Pharma News - May 3, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
'Black sheep' of helper T cells may hold key to precision allergy treatment
A new Nature Immunology study led by University of Pittsburgh and National Institutes of Health researchers sheds light on how a rare type of helper T cell, called Th9, can drive allergic disease, suggesting new precision medicine approaches to treating allergies in patients with high levels of Th9. (Source: World Pharma News)
Source: World Pharma News - May 3, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Chances of eliminating HIV infection increased by novel dual gene-editing approach
Gene-editing therapy aimed at two targets - HIV-1, the virus that causes AIDS, and CCR5, the co-receptor that helps the virus get into cells - can effectively eliminate HIV infection, new research from the Lewis Katz School of Medicine at Temple University and the University of Nebraska Medical Center (UNMC) shows. The study, published online in the journal The Proceedings of the National Academy of Sciences (PNAS), is the first to combine a dual gene-editing strategy with antiretroviral drugs to cure animals of HIV-1. (Source: World Pharma News)
Source: World Pharma News - May 2, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Improved gene editing method could power the next generation of cell and gene therapies
A new approach to the genetic engineering of cells promises significant improvements in speed, efficiency, and reduction in cellular toxicity compared to current methods. The approach could also power the development of advanced cell therapies for cancers and other diseases, according to a study from researchers in the Perelman School of Medicine at the University of Pennsylvania. (Source: World Pharma News)
Source: World Pharma News - May 1, 2023 Category: Pharmaceuticals Tags: Featured Events Source Type: news
